In that context, molecular characterization of epithelial circulating cells in patients with disseminated ovarian cancer has shown significantly high expression of TIMP-1 suggesting the utility of TIMP-1 as a biomarker for disseminated disease (61). This evidence concerns the gene TIMP1 and ovarian carcinoma.